This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H7N9 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H7N9 Hemagglutinin (HA), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 57.7 kDa. The purity is>85% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
Avian influenza A(H7N9) is a subtype of influenza viruses previously identified in birds. This specific A(H7N9) strain had not been observed in either animals or humans until its discovery in China in March 2013. The hemagglutinin (HA) protein of the influenza virus is a key glycoprotein that plays a vital role in the early stages of viral infection.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.